Literature DB >> 27418193

Targeted re-sequencing of TET2 in Taiwanese patients with myelodysplastic/myeloproliferative neoplasms.

Huan-Chau Lin1, Daw-Yang Hwang2, Ken-Hong Lim3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27418193     DOI： 10.1007/s12032-016-0808-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  3 in total

1.  Prognostic score including gene mutations in chronic myelomonocytic leukemia.

Authors:  Raphaël Itzykson; Olivier Kosmider; Aline Renneville; Véronique Gelsi-Boyer; Manja Meggendorfer; Margot Morabito; Céline Berthon; Lionel Adès; Pierre Fenaux; Odile Beyne-Rauzy; Norbert Vey; Thorsten Braun; Torsten Haferlach; François Dreyfus; Nicholas C P Cross; Claude Preudhomme; Olivier A Bernard; Michaela Fontenay; William Vainchenker; Susanne Schnittger; Daniel Birnbaum; Nathalie Droin; Eric Solary
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

2.  Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.

Authors:  Emnet A Wassie; Raphael Itzykson; Terra L Lasho; Olivier Kosmider; Christy M Finke; Curtis A Hanson; Rhett P Ketterling; Eric Solary; Ayalew Tefferi; Mrinal M Patnaik
Journal:  Am J Hematol       Date:  2014-09-26       Impact factor: 10.047

Review 3.  Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.

Authors:  M M Patnaik; A Tefferi
Journal:  Blood Cancer J       Date:  2016-02-05       Impact factor: 11.037
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.